Immune system |
Reactome |
1011 |
2.16939E − 11 |
3.90490E − 09 |
28 |
□ |
|
Pathways in cancer |
KEGG |
327 |
3.68916E − 09 |
3.32025E − 07 |
15 |
|
□ |
NF-kappa B signaling pathway |
KEGG |
92 |
1.01889E − 08 |
6.11336E − 07 |
9 |
□ |
□ |
Hepatitis C |
KEGG |
133 |
1.90274E − 08 |
8.56232E − 07 |
10 |
|
|
Cytokine signaling in immune system |
Reactome |
186 |
4.29066E − 08 |
1.41014E − 06 |
11 |
□ |
|
Signaling events mediated by stem cell factor receptor (c-Kit) |
PID |
53 |
5.95581E − 08 |
1.41014E − 06 |
7 |
□ |
□ |
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
Reactome |
53 |
5.95581E − 08 |
1.41014E − 06 |
7 |
□ |
|
IL2 signaling events mediated by STAT5 |
PID |
32 |
6.26727E − 08 |
1.41014E − 06 |
6 |
□ |
□ |
EPO signaling pathway |
PID |
34 |
9.20249E − 08 |
1.8405E − 06 |
6 |
□ |
|
Epstein-Barr virus infection |
KEGG |
204 |
1.10634E − 07 |
1.99141E − 06 |
11 |
|
|
Neurotrophic factor-mediated Trk receptor signaling |
PID |
65 |
2.52184E − 07 |
4.09444E − 06 |
7 |
□ |
|
Measles |
KEGG |
134 |
2.72963E − 07 |
4.09444E − 06 |
9 |
□ |
|
TRAF3-dependent IRF activation pathway |
Reactome |
13 |
1.33772E − 06 |
1.71993E − 05 |
4 |
|
□ |
Signaling events mediated by hepatocyte growth factor receptor (c-Met) |
PID |
84 |
1.48134E − 06 |
1.77760E − 05 |
7 |
|
□ |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
Reactome |
15 |
2.52771E − 06 |
2.84368E − 05 |
4 |
□ |
□ |
MyD88-independent cascade |
Reactome |
97 |
3.91774E − 06 |
3.71155E − 05 |
7 |
□ |
|
Toll-like receptor 3 (TLR3) cascade |
Reactome |
97 |
3.91774E − 06 |
3.71155E − 05 |
7 |
□ |
□ |
Beta-catenin phosphorylation cascade |
Reactome |
17 |
4.36224E − 06 |
3.92601E − 05 |
4 |
□ |
□ |
Platelet sensitization by LDL |
Reactome |
18 |
5.57985E − 06 |
4.78273E − 05 |
4 |
□ |
|
Interferon signaling |
Reactome |
69 |
6.80349E − 06 |
5.56649E − 05 |
6 |
□ |
□ |
Signaling events mediated by TCPTP |
PID |
41 |
7.79283E − 06 |
6.03140E − 05 |
5 |
□ |
□ |
RIG-I-like receptor signaling pathway |
KEGG |
71 |
8.04187E − 06 |
6.03140E − 05 |
6 |
□ |
□ |
Chronic myeloid leukemia |
KEGG |
73 |
9.45705E − 06 |
6.65100E − 05 |
6 |
□ |
□ |
Activated TLR4 signaling |
Reactome |
111 |
9.60700E − 06 |
6.65100E − 05 |
7 |
□ |
□ |
Negative regulators of RIG-I/MDA5 signaling |
Reactome |
21 |
1.07467E − 05 |
7.16445E − 05 |
4 |
|
|
Signaling by interleukins |
Reactome |
114 |
1.14527E − 05 |
7.36243E − 05 |
7 |
□ |
□ |
Inhibition of cellular proliferation by Gleevec |
PID |
22 |
1.30676E − 05 |
8.11090E − 05 |
4 |
□ |
□ |
Interleukin-3, interleukin-5, and GM-CSF signaling |
Reactome |
47 |
1.54549E − 05 |
8.74477E − 05 |
5 |
□ |
|
CTLA4 inhibitory signaling |
Reactome |
23 |
1.57376E − 05 |
8.74477E − 05 |
4 |
□ |
|
Neurotrophin signaling pathway |
KEGG |
120 |
1.60321E − 05 |
8.74477E − 05 |
7 |
|
|